ELCC 2019 Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer

ELCC 2019: Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer

11:02 EDT 11 Apr 2019 | ecancermedicalscience

Maintenance immunotherapy fails to improve survival in extensive-stage small cell lung cancer (SCLC), according to late-breaking results from the CheckMate 451 study to be presented today at the European Lung Cancer Congress 2019 (ELCC).  Around 60–70...

More From BioPortfolio on "ELCC 2019: Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer"